Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-260265) and Form S-8s (No. 333-248682 and No. 333-273576) of Silence Therapeutics plc of our report dated March 13, 2024 relating to the financial statements, which appears in this Form 20-F.
/s/ PricewaterhouseCoopers LLP
Reading, United Kingdom
March 13, 2024